Heartworm Infection Research Articles

Exotic disease and an insular endemic carnivore, the island fox

Diseases pose serious threats to rare species, and mammalian carnivores on islands may be especially susceptible. The objective of our study was to assess the prevalence of an exotic pathogen, heartworm, in an insular endemic carnivore, the island fox. Because the island fox is an insular endemic and presumably vulnerable to exotic parasites, we expected that the prevalence of heartworm would be higher in island foxes than in their closest relative, the mainland gray fox. We also determined the age structure of island foxes; because heartworm is a progressive disease that may ultimately be fatal, we suspected that heartworm infection might contribute to a shift to a relatively young age structure, reflecting increased mortality of older individuals. We found that 78% of the island foxes tested positive for heartworm antigen, in contrast to a 5% prevalence of antigen-positive results in gray foxes on mainland California. Few mature or old foxes existed in the island fox population compared with two decades ago. Our results expose heartworm as a possible threat to island foxes, and underscore the vulnerability of insular endemic species to exotic parasites.

Other ways to interpret results from heartworm infection study

Other ways to interpret results from heartworm infection study

Relationship between microfilaria count and sensitivity of the direct smear for diagnosis of canine dirofilariosis

Direct blood smear examination (using 0.05 ml of whole blood) detected 168 (80.9%) of 204 microfilaremic canine blood samples as determined by the modified Knott test for microfilariae (mff) of Dirofilaria immitis (using 1 ml of whole blood). Direct smear examination detected all of 134 microfilaremias greater than 50 mff ml −1, but only 31 of 70 (44.3%) microfilaremias having less than 50 mff ml −1. In a separate retrospective query of a database of 963 dogs with necropsy-confirmed heartworm infections, 834 (86.6%) were positive by the DiroCHEK heartworm antigen test, and 504 (52.3%) were microfilaremic by the modified Knott test. Only 2 (0.4%) of the microfilaremic dogs were DiroCHEK negative and another 18 (3.6%) were very weak positives. Although these microfilaremic dogs were not tested by direct smear, only one of the two DiroCHEK-negative and six of 18 weakly DiroCHEK-positive dogs had microfilaremias so low that a direct smear may have given a false negative result. Significant adverse reactions to either diethylcarbamazine or the macrolide endectocides have not been reported for microfilaremias less than 500 mff ml −1, thus substitution of the direct smear for a concentration test for mff, such as the modified Knott test or membrane filtration, does not appear to increase the risk of an unexpected adverse reaction to heartworm prophylactic drugs. Such a substitution results in only a very slight decrease (on the order of 0.1%) in the overall sensitivity of heartworm screening, provided a test for mff is run concurrently with an antigen test. If a test for mff is the only screening test used, then substitution of a direct smear for a concentration test may decrease the sensitivity of heartworm screening by nearly 20%, depending on the prevalence of low level microfilaremias in the population of dogs tested.

Prevalence of heartworm infection in healthy cats in the lower peninsula of Michigan.

To determine prevalence of heartworm infection among healthy, client-owned cats in the lower peninsula of Michigan. Cross-sectional prevalence study. 1,348 healthy cats examined at private veterinary practices throughout the lower peninsula of Michigan. Sera were tested by use of an ELISA-based antigen test kit to determine infection and 2 commercially available antibody detection kits to determine exposure. A questionnaire was used to collect data to assess risk factors associated with infection. 25 cats had positive results for heartworm antigen, yielding an observed prevalence of 1.9%. Neither antibody test was reliable or provided reproducible results, and neither yielded positive results for more than 20% of the antigen-positive heartworm-infected cats. Multivariate regression indicated that cats from southeastern Michigan and cats > or = 2 years old had a higher risk of infection. Results indicated that most (80%) heartworm-infected cats in the lower peninsula of Michigan were from the southeastern part of the state, a pattern that closely paralleled the prevalence of heartworm infection in dogs. Therefore, knowledge of the regional prevalence of heartworm infection in dogs may be useful in assessing the risk of infection in cats. Results also suggested that currently available in-clinic heartworm antibody detection kits have limited utility in the diagnosis of heartworm infection in cats.

Prevalence of dirofilarial infection in raccoon dogs in Japan

The raccoon dog ( Nyctereutes procyonoides viverrinus) is known to acquire canine heartworm ( Dirofilaria immitis) infection. We surveyed the prevalence of heartworm infection in free-ranging raccoon dogs in the Nishi-Tama (Tokyo) and Kanagawa areas of Japan. A total of 75 raccoon dog carcasses, including 29 animals from the Nishi-Tama area and 46 from the Kanagawa area, were necropsied between 1992 and 1993. Eight out of 75 raccoon dogs were found to be infected (overall 10.7%). The prevalence of infection was 6 and 16% in Nishi-Tama and Kanagawa, respectively. Microfilarial production was observed in the uterus of one female adult dog.

Heartworm infection in cats: 50 cases (1985-1997).

To characterize risk factors, clinical findings, usefulness of diagnostic tests, and prognosis in cats with naturally occurring heartworm infection (HWI). Retrospective study. 50 cats with Dirofilaria immitis infection. Medical records, thoracic radiographs, and echocardiograms were reviewed and findings compared with appropriate reference populations. Findings suggested that male cats were not predisposed to HWI, domestic shorthair cats were at increased risk, and indoor housing was only partially protective. Fewer cases of HWI were identified in the final quarter of the year, compared with other periods, and prevalence is not apparently increasing. Signs of respiratory tract disease were most common, followed by vomiting. Infection was diagnosed incidentally in > 25% of cats; conversely, 10% of infected cats died suddenly without other clinical signs. Serologic tests were most useful for diagnosis, followed by radiography and echocardiography. Eosinophilia supported the diagnosis. Overall median survival time was 1.5 years but exceeded 4 years in cats surviving beyond the day of diagnosis. Sex does not appear to be a risk factor for HWI in cats, and indoor housing provides only incomplete protection. Signs of respiratory tract disease (dyspnea and cough) are the strongest indicators of HWI in cats, and some radiographic evidence of infection is detected in most cases. Antibody screening for HWI in cats is efficacious, and antigen testing and echocardiography are most useful for making a definitive antemortem diagnosis.

Prevention of experimentally induced heartworm ( Dirofilaria immitis) infections in dogs and cats with a single topical application of selamectin

In a series of six controlled studies (four in dogs, two in cats), heartworm-free dogs and cats were inoculated with Dirofilaria immitis larvae (L 3) prior to topical treatment with the novel avermectin selamectin or a negative control containing inert formulation ingredients (vehicle). Selamectin and negative-control treatments were administered topically to the skin at the base of the neck in front of the scapulae. In dogs, selamectin was applied topically at dosages of 3 or 6 mg kg −1 at 30 days post-inoculation (PI), or of 3 or 6 mg kg −1 at 45 days PI, or of 6 mg kg −1 at 60 days PI. Cats were treated topically with unit doses providing a minimum dosage of 6 mg kg −1 selamectin at 30 days PI. Of the animals that were treated 30 days PI, some dogs were bathed with water or shampoo between 2 and 96 h after treatment, and some cats were bathed with shampoo at 24 h after treatment. Between 140 and 199 days PI, the animals were euthanized and examined for adult D. immitis. Adult heartworms developed in all control dogs (geometric mean count, 18.7 worms) and in 88% of control cats (geometric mean count, 2.1 worms). Selamectin was 100% effective in preventing heartworm development in dogs when administered as a single topical dose of 3 or 6 mg kg –1 at 30 days after infection, 3 or 6 mg kg −1 at 45 days after infection, or 6 mg kg −1 at 60 days after infection. Selamectin was 100% effective against heartworm infections in cats when administered as a single topical unit dose of 6 mg kg −1. Bathing with water or shampoo between 2 and 96 h after treatment did not reduce the efficacy of selamectin as a heartworm prophylactic in dogs. Likewise, bathing with shampoo at 24 h after treatment did not reduce the efficacy of selamectin in cats. These studies demonstrated that, at the recommended dosage and treatment interval, a single topical administration of selamectin was 100% effective in preventing the development of D. immitis in dogs and cats.

Prevalence of Dirofilaria immitis infection among shelter cats

To determine prevalence of Dirofilaria immitis infection among shelter cats. Cross-sectional study. 239 cats euthanatized at an animal shelter in southeastern Michigan. A gross necropsy focusing on the thoracic cavity, heart, lungs, and pulmonary vessels was performed within 5 hours after cats were euthanatized. Blood was collected directly from the heart of cats found to be infected and tested, using a filter test for microfilariae. Serum was tested for D immitis antigens by use of 2 antigen detection kits and for D immitis-specific antibodies by use of 2 antibody detection kits. Cats ranged from approximately 4 months to 15 years old. Adult D immitis were found in 6 (2.5%) cats. Blood could not be recovered from 1 of the cats with heartworm infection. For the 5 other cats, results of the filter test were negative, and results of both antigen and both antibody tests were positive. Results suggest that cats living in an urban area in the northern part of the United States have a low prevalence of adult D immitis infection. However, this is likely to be an underestimate of the true prevalence of infection, because no attempts were made to identify cats infected with larval or juvenile stages of D immitis.

Efficacy and safety of selamectin against fleas and heartworms in dogs and cats presented as veterinary patients in North America

A series of randomized, controlled, masked field studies was conducted to assess the efficacy and safety of selamectin in the treatment of flea infestations on dogs and cats, and in the prevention of heartworm infection in dogs. In addition, observations were made on the beneficial effect of selamectin treatment on dogs and cats showing signs of flea allergy dermatitis (FAD). In all studies selamectin was applied topically, once per month, in unit doses providing a minimum dosage of 6 mg kg −1. Dogs and cats with naturally occurring flea infestations, some of which also had signs associated with FAD, were assigned randomly to receive three months of topical treatment with selamectin (220 dogs, 189 cats) or a positive-control product (dogs: fenthion, n=81; cats: pyrethrins, n=66). Selamectin was administered on days 0, 30, and 60. Day 0 was defined as the day that the animal first received treatment. Flea burdens were assessed by flea comb counts and clinical evaluations of FAD were performed before treatment, and on days 14, 30, 60, and 90. On days 30, 60, and 90, mean flea counts in selamectin-treated dogs were reduced by 92.1, 99.0, and 99.8%, and mean flea counts in fenthion-treated dogs were reduced by 81.5, 86.8, and 86.1%, respectively, compared with day 0 counts. Also, on days 30, 60, and 90, mean flea counts in selamectin-treated cats were reduced by 92.5, 98.3, and 99.3%, and mean flea counts in pyrethrin-treated cats were reduced by 66.4, 73.9, and 81.3%, respectively, compared with day 0 counts. Selamectin also was beneficial in alleviating signs in dogs and cats diagnosed clinically with FAD. A total of 397 dogs free of adult heartworm infection from four heartworm-endemic areas of the USA were allocated randomly to six months of treatment with selamectin ( n=298) or ivermectin ( n=99). Selamectin achieved a heartworm prevention rate of 100%, with all dogs testing negative for microfilariae and adult heartworm antigen on days 180 and 300. Selamectin was administered to a total of 673 dogs and 347 cats having an age range of 6 weeks to 19 years (3954 doses). The animals included 19 purebred or crossbred Collies (Bearded, Border, and unspecified). There were no serious adverse events. Results of these studies indicated that selamectin was highly effective in the control of flea infestations in dogs and cats without the need for simultaneous treatment of the environment or of in-contact animals and also was beneficial in alleviating signs associated with FAD. Selamectin also was 100% effective in preventing the development of canine heartworms and was safe for topical use in dogs and cats.

Efficacy of selamectin in the prevention of adult heartworm ( Dirofilaria immitis) infection in dogs in northern Italy

The efficacy of a novel avermectin, selamectin, was evaluated for the prevention of heartworm disease (adult Dirofilaria immitis infection) in 120 dogs (aged 9 months to 13 years at enrolment) presented as veterinary patients. The study was conducted at five veterinary practices in a heartworm hyperendemic region of northern Italy. Dogs were allocated randomly in a 2:1 ratio to treatment with either selamectin or ivermectin. Treatments were administered at monthly intervals for 6 months during the heartworm transmission season (May–November). Selamectin was applied topically in a single spot to the skin on each animal’s back at the base of the neck in front of the scapulae as a unit dose that provided at least the minimum recommended dosage of 6 mg kg −1 (range, 6–12 mg kg −1). Ivermectin (6 μg kg −1 of body weight) was administered orally at monthly intervals, in accordance with the manufacturer’s product label recommendations. Study day 0 was defined individually for each dog as the day of first treatment administration. Efficacy was assessed on the basis of the absence of D. immitis microfilariae and adult heartworm ( D. immitis) antigen in tests conducted on days 180 and 300. There were no adverse clinical signs arising due to treatment with selamectin and no drug-related mortalities. The prevention rate for D. immitis microfilariae and adult heartworm antigen was 100% for both selamectin and ivermectin. Thus, selamectin administered as a unit dose, providing at least the recommended minimum dosage of 6 mg kg –1, at monthly intervals during the heartworm transmission season was safe and 100% effective in the prevention of heartworm disease in dogs presented as veterinary patients.

Effects of canine heartworm (Dirofilaria immitis) on body condition and activity of free-ranging coyotes (Canis latrans)

We used radiotelemetry to study relationships among canine heartworm (Dirofilaria immitis) infection, body condition, and activity of free-ranging coyotes (Canis latrans). Average body mass at death was lower for 17 coyotes in a high-intensity infected group (mean = 33.6 heartworms) than for 18 coyotes in a control group (mean = 3.6 heartworms; p < 0.01). Coyotes in the infected group lost body mass at an average rate of 20% per year relative to the control group (p < 0.01). Bone marrow fat was negatively correlated with heartworm burden (R2 = 0.27; p < 0.01). Average body mass of coyotes at initial capture (i.e., potentially before infection) did not differ between infected and control groups (p = 0.90; 1–β = 0.70). Activity was negatively correlated with heartworm burden during the last 2 months of life (R2 = 0.30; p < 0.01), but no correlation was found 2–4 months before death. Activity of the infected group (n = 13) declined over time (p = 0.01), whereas no difference in activity was observed in the control group (n = 13; p = 0.50). Our findings indicate that heartworm infection reduced body condition and activity of coyotes but that nutritional status did not significantly affect susceptibility to infection.

Clinical and laboratory observations in 91 dogs infected with Dirofilaria immitis in northern Greece

The medical records of 91 dogs with heartworm (Dirofilaria immitis) infection were reviewed, and diagnoses were established by using parasitological and immunological methods. Twenty-one animals were asymptomatic (stage 1), 57...

Effects of canine heartworm (<i>Dirofilaria immitis</i>) on body condition and activity of free-ranging coyotes (<i>Canis latrans</i>)

We used radiotelemetry to study relationships among canine heartworm (Dirofilaria immitis) infection, body condition, and activity of free-ranging coyotes (Canis latrans). Average body mass at death was lower for 17 coyotes in a high-intensity infected group (x = 33.6 heartworms) than for 18 coyotes in a control group (x = 3.6 heartworms; p < 0.01). Coyotes in the infected group lost body mass at an average rate of 20% per year relative to the control group (p < 0.01). Bone marrow fat was negatively correlated with heartworm burden (R 2 = 0.27; p < 0.01). Average body mass of coyotes at initial capture (i.e., potentially before infection) did not differ between infected and control groups (p = 0.90; 1 -β = 0.70). Activity was negatively correlated with heartworm burden during the last 2 months of life (R 2 = 0.30; p < 0.01), but no correlation was found 2-4 months before death. Activity of the infected group (n = 13) declined over time (p = 0.01), whereas no difference in activity was observed in the control group (n = 13; p = 0.50). Our findings indicate that heartworm infection reduced body condition and activity of coyotes but that nutritional status did not significantly affect susceptibility to infection.

Survey of canine heartworm in the city of Recife, Pernambuco, Brazil.

Six hundred and eleven random-source dogs (338 male, 273 female) one year of age or older, from six sections of the city of Recife, Pernambuco, were examined antemortem for circulating microfilariae Dirofilaria immitis and Dipetalonema reconditum adult heartworm (D. immitis) antigen, and examined postmortem for adult heartworms. The prevalence of heartworm infection was 2.3% (14/611), as determined by necropsy for adult worms, and 1% (6/611) had circulating microfilariae of D. immitis; thus, 57.1% of the heartworm-infected dogs had occult infections. The results of serological testing indicated that 1.3% (8/611) of the dogs were positive for adult heartworm antigen. A total of 42 (6.9%) of the dogs had microfilariae of D. reconditum; 40 of these had only D. reconditum and two additional dogs had microfilariae of both species, D. immitis and D. reconditum.

The diagnosis of feline heartworm infection.

The diagnosis of feline heartworm infection.

Antibody to the Dirofilaria immitis Aspartyl Protease Inhibitor Homologue Is a Diagnostic Marker for Feline Heartworm Infections

Feline heartworm disease, caused by the filarial nematode Dirofilaria immitis, has been diagnosed with increased frequency in areas endemic for canine heartworm infection. The routine methods for determining the infection status of dogs, such as identification of circulating microfilariae in blood or identification of circulating antigen in serum, plasma or blood, have proven inadequate for screening cats. The inadequacies are due to the likelihood of single-sex infections and clinical disease during prepatent infections. Current antibody detection methodologies rely on crude or partially purified worm antigen preparations that may result in poor specificity. This report describes the cloning, expression, and diagnostic utility of the D. immitis homologue (PDi33) of the Onchocerca volvulus aspartyl protease inhibitor (Ov33). PDi33 is present in all stages that occur in the mammalian host (microfilariae, L3, L4, adult males, and females) and is released by adults cultured in vitro. An indirect enzyme-linked immunosorbent assay (ELISA) using antibody to recombinant PDi33 as a diagnostic marker for infection in cats was very sensitive and was useful for identifying prepatent infections. Testing of sera from cats infected with common gastrointestinal parasites also indicated excellent specificity. The same ELISA in dogs, although demonstrating reasonable sensitivity and specificity, appeared to be of less value as compared with the currently accepted antigen detection methodologies.

The serologic diagnosis of heartworm infection in dogs and cats

W hether performing routine screening of asymptomatic dogs or confirming heartworm infection in dogs with suggestive clinical signs, veterinarians rely heavily on the use of serologic tests. With recent advances in serology, the potential now exists for veterinarians to use these tests in the diagnosis of heartworm disease in cats. Heartworm assays today also allow semiquantification of heartworm infection allowing the practitioner to better plan adulticide therapy considering disease severity. These assays also are used in the assessment of adulticidal efficacy. Considering the geographical increase of heartworm endemic areas and the prevalence of heartworm disease in dogs and cats, these tests are integral components of veterinary practice. This report reviews the temporal serologic consequences of heartworm infection, the varying methods of serologic testing, and guidelines for the practical use of these tests m veterinary practice.

Seasonality of heartworm infection and implications for chemoprophylaxis

The current emphasis on heartworm prevention reflects the dependable protection provided by the monthly administered macrolide endectocides. This article reviews the prerequisites for heartworm transmission and the importance of daily temperature as a limiting factor in determining the seasonality of the transmission period. The practice of some veterinarians to continuously prescribe monthly chemoprophylaxis exaggerates the actual risk of heartworm transmission in most parts of the country and unnecessarily increases the cost of protection to their clients. Guidelines are provided for making an objective, conservative estimate of the earliest and latest dates for administering monthly chemoprophylaxis; and the use of seasonal projections for other clinical applications such as timing and interpretation of heartworm testing are discussed.

Increasing prevalence of canine heartworm in coyotes from California.

Thirty-seven subadult and adult coyotes (Canis latrans), collected August 1992 through December 1996 from a coastal foothill area in northern California (USA), were examined for adult heartworm (Dirofilaria immitis). During 1992 through 1993, at the end of a 6 yr drought, none of four coyotes examined were infected with heartworms. However, during 1994 through 1996, after the drought had ended, prevalences were 91% in 23 adult coyotes and 40% in 10 subadult coyotes. Heartworm intensity did not differ by sex of coyote, and averaged (+/- SE) 19.4 +/- 3.8 among adults; one subadult had > 238 heartworms. The prevalence and intensity of heartworm infection in coyotes reported here for 1994 through 1996 are the highest reported anywhere in the United States.

Prevalence of heartworm infection in cats with signs of cardiorespiratory abnormalities

Objective To determine prevalence of heartworm infection in a population of pet cats with cardiorespiratory abnormalities and to determine relative usefulness of clinical signs and tests in diagnosis of heartworm disease. Design Prospective case series. Animals 100 client-owned cats with clinical signs of cardiorespiratory abnormalities. Procedure Cats were evaluated using CBC, modified Knott test, ELISA for serologic detection of heartworm antigen and antibodies to heartworms, thoracic radiography, and echocardiography. Cats were considered infected if they had circulating microfilaria, heartworm antigens in serum, or if heartworms were detected by echocardiography or on necropsy. Cats were considered suspicious for infection if they had 2 of the following: serum antibodies to heartworms, eosinophilia or basophilia, or indicative radiographic findings. Results 9 cats were infected with heartworms, resulting in a prevalence of 9%; 26 cats had evidence of heartworm exposure (ie, serum antibodies to heartworms). Twenty cats were considered suspicious for heartworm infection. Some outdoor exposure was reported twice as often in heartworm-infected cats, compared with noninfected and suspicious cats. However, a third of infected cats were reportedly housed totally indoors. Cough and dyspnea were strong indicators of heartworm disease. Eight of 9 infected cats had serum antibodies to heartworms and heartworm antigen in serum. Thoracic radiography and echocardiography indicated heartworm infection in 6 and 7 of the 9 cats, respectively. Clinical Implications Cough or dyspnea may indicate heartworm disease in cats; serologic tests, echocardiography, and radiography are most useful diagnostic procedures. Although living indoors is protective, it may not preclude heartworm infection in cats. (J Am Vet Med Assoc 1998; 212:517-520)